Newtyn Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-165,000
| Closed | -$1.75M | – | 44 |
|
|
2024
Q1 | $1.75M | Sell |
165,000
-481,760
| -74% | -$5.12M | 0.35% | 31 |
|
|
2023
Q4 | $5.9M | Buy |
646,760
+146,760
| +29% | +$1.34M | 1.16% | 23 |
|
|
2023
Q3 | $5.19M | Sell |
500,000
-183,648
| -27% | -$1.9M | 1.28% | 21 |
|
|
2023
Q2 | $9.79M | Buy |
683,648
+1,621
| +0.2% | +$23.2K | 2.31% | 15 |
|
|
2023
Q1 | $4.87M | Buy |
682,027
+197,953
| +41% | +$1.41M | 0.96% | 32 |
|
|
2022
Q4 | $5.43M | Buy |
484,074
+168,099
| +53% | +$1.89M | 1.12% | 27 |
|
|
2022
Q3 | $3.5M | Buy |
315,975
+60,208
| +24% | +$667K | 0.77% | 32 |
|
|
2022
Q2 | $2.16M | Buy |
+255,767
| New | +$2.16M | 0.41% | 39 |
|